Clinical Trial Update: Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity [Phase 3]

View source ↗

Summary

Phase 3 trial assessing Leukocyte Interleukin Injection (LI) for squamous cell carcinoma of the oral cavity and soft palate has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Soft Palate

Drugs mentioned

• Leukocyte Interleukin Injection (Leukocyte Interleukin Injection)

Snippet

Sponsor: CEL-SCI Corporation | Conditions: Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate | Phase 3 | Status: COMPLETED | Results posted: 2022-08-19